Understanding Clinical Trials
1,148 members195 posts

Is a trial that synthesises one component good for the patient?

I have just watched


which has the interesting take-away many if not most trials are funded to make money by extracting and/or synthesising an interesting chemical from one plant or another. They do this because they can create a pill out of the results and also because trial are easier to organise.

But is that going to lead the best solution for the patient? Is the whole better than the sum of the parts?

1 Reply

This is the insidious nature of drug companies. I.E. the new blood thinners, come from the use of the natural enzymes of Nattokinase, and Serrapeptase, over Warfarin. They do this all the time.



You may also like...